settlement that resulted in no payment to Covance, and with PETA allowed to continue to publish the video. New code In response to the controversy, Covance issued a statement undertaking to observe a number of principles, including treating the animals in its care with respect, abiding by all applicable laws and regulations, employing alternatives where appropriate, minimizing animal discomfort and stress, training employees, and encouraging them to report any misconduct. References Further reading Centers for Disease Control and Prevention. "Known Cases and Outbreaks of Ebola Hemorrhagic Fever, in Chronological Order", 12 October 2011. Covance. "2011 Annual report". Covance Laboratories Inc v. People for the Ethical Treatment of Animals, et al., Chancery No. 2005–2590 (Va. Cir. Ct., Fairfax City, June 3, 2005. Covance Laboratories Ltd, et al. v. Covance Campaign, et al., Claim Nom 5C-00295, High Court of Justice, Chancery Division, June 16, 2005. Mirowski, Philip and Van Horn, Robert. "The Contract Research Organization and the Commercialization of Scientific Research", Social Studies of Science, Vol. 35, No. 4 (August 2005), pp. 503–548. Companies formerly listed on the New York Stock Exchange Animal testing in the United States Companies based in Princeton, New Jersey American companies established in 1997 Contract research organizations Pharmaceutical companies based in New Jersey Corning Inc. 2014 mergers and acquisitions 1997 establishments in New Jersey Biotechnology companies established in 1997 Pharmaceutical companies established in 1997